What is The Oncology Institute, Inc.'s revenue?

The Oncology Institute, Inc. (TOI) generated $545.8M in revenue over the trailing twelve months, up 35.4% year over year.

Is The Oncology Institute, Inc. profitable?

The Oncology Institute, Inc. is not currently profitable: it reported a net loss of $43.5M over the trailing twelve months, a -8.0% net margin.

What is The Oncology Institute, Inc.'s earnings per share?

The Oncology Institute, Inc.'s diluted EPS over the trailing twelve months is $-0.36.

Where does The Oncology Institute, Inc.'s income statement data come from?

Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

The Oncology Institute, Inc. TOI Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$502.73M+27.8%	$393.41M+21.3%	$324.24M+28.4%	$252.48M+24.4%
Selling, general and administrative	$105.57M-2.1%	$107.83M-5.3%	$113.85M-4.9%	$119.69M+43.6%
Depreciation and amortization	$6.94M+10.5%	$6.29M+7.0%	$5.87M+33.1%	$4.41M+32.0%
Total costs & expenses	$538.81M+18.8%	$453.53M+13.0%	$401.26M+20.0%	$334.43M+34.4%
Operating income	-$36.08M+40.0%	-$60.12M+21.9%	-$77.02M+6.0%	-$81.95M-78.7%
Operating margin	-7.2%+8.1pp	-15.3%+8.5pp	-23.8%+8.7pp	-32.5%-9.9pp
Interest expense	$11.28M+50.4%	$7.5M+10.6%	$6.78M—	——
Other income (expense), net	-$24.65M-442%	-$4.55M+25.3%	-$6.09M-107%	$81.86M+139%
Income before income taxes	-$60.74M+6.1%	-$64.66M+22.2%	-$83.1M-91,223%	-$91K+99.2%
Income tax expense	-$131K—	$0+100%	-$36K+85.2%	-$243K+63.8%
Net income	-$60.61M+6.3%	-$64.66M+22.2%	-$83.07M—	——
Net margin	-12.1%+4.4pp	-16.4%+9.2pp	-25.6%—	——
Diluted earnings per share	-$0.55+23.6%	-$0.72+21.7%	-$0.92-360%	-$0.20-17.6%
Basic earnings per share	-$0.55+23.6%	-$0.72+21.7%	-$0.92-9,300%	$0.01+106%
Weighted-average shares, diluted	360.2M+20.2%	299.6M+1.6%	294.8M-4.7%	309.4M+18.5%
Weighted-average shares, basic	360.2M+20.2%	299.6M+1.6%	294.8M+1.2%	291.2M+11.5%
Derivative, Gain (Loss) on Derivative, Net	-$13.27M-592%	$2.7M—	——	$24.2M—
Other income, net (Note 6)	——	-$365K+48.2%	-$704K-241%	$501K-55.5%
Revenue From Contract With Customer Excluding Assessed Tax	$502.73M+27.8%	$393.41M+21.3%	$324.24M+28.4%	$252.48M+24.4%
EBIT	-$36.08M+40.0%	-$60.12M+21.9%	-$77.02M+6.0%	-$81.95M-78.7%
EBITDA	-$29.14M+45.9%	-$53.83M+24.3%	-$71.15M+8.2%	-$77.54M-82.4%
EBITDA	-$29.14M+45.9%	-$53.83M+24.3%	-$71.15M+8.2%	-$77.54M-82.4%
EBITDA margin	-5.8%+7.9pp	-13.7%+8.3pp	-21.9%+8.8pp	-30.7%-9.8pp
EBIT	-$36.08M+40.0%	-$60.12M+21.9%	-$77.02M+6.0%	-$81.95M-78.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about The Oncology Institute, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is The Oncology Institute, Inc.'s revenue?: The Oncology Institute, Inc. (TOI) generated $545.8M in revenue over the trailing twelve months, up 35.4% year over year.
Is The Oncology Institute, Inc. profitable?: The Oncology Institute, Inc. is not currently profitable: it reported a net loss of $43.5M over the trailing twelve months, a -8.0% net margin.
What is The Oncology Institute, Inc.'s earnings per share?: The Oncology Institute, Inc.'s diluted EPS over the trailing twelve months is $-0.36.
Where does The Oncology Institute, Inc.'s income statement data come from?: Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.